RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
RNA splicing is an essential step in producing mature messenger RNA (mRNA) and other RNA species. Harnessing RNA splicing modifiers as a new pharmacological modality is promising for the treatment of diseases caused by aberrant splicing. This drug modality can be used for infectious diseases by disr...
Main Authors: | Zhichao Tang, Junxing Zhao, Zach J. Pearson, Zarko V. Boskovic, Jingxin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/8/2263 |
Similar Items
-
Principles and correction of 5’-splice site selection
by: Florian Malard, et al.
Published: (2022-12-01) -
An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the <i>MSTN</i> Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin Inhibitor
by: Kazuhiro Maeta, et al.
Published: (2022-04-01) -
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
by: Prithi Raguraman, et al.
Published: (2021-11-01) -
Regulating PCCA gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia
by: Ulrika Simone Spangsberg Petersen, et al.
Published: (2024-03-01) -
Aberrant RNA Splicing in Cancer and Drug Resistance
by: Bi-Dar Wang, et al.
Published: (2018-11-01)